These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 3869424)

  • 1. Are plasma lipoproteins responsible for the excess atherosclerosis in diabetes?
    Nikkilä EA
    Acta Endocrinol Suppl (Copenh); 1985; 272():27-30. PubMed ID: 3869424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dyslipidemias in patients with diabetes mellitus: classification and risks and benefits of therapy.
    Oki JC
    Pharmacotherapy; 1995; 15(3):317-37. PubMed ID: 7667166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetic dyslipidemia and atherosclerosis.
    Shepherd J
    Schweiz Med Wochenschr; 1994 Nov; 124(44):1933-7. PubMed ID: 7973520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of metabolic control of the serum lipid and lipoprotein levels on insulin-dependent diabetes mellitus.
    Romics L; Karádi I; Rozenberczki M; Kammerer L
    Acta Med Acad Sci Hung; 1982; 39(3-4):117-23. PubMed ID: 6764327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Triglyceride-rich lipoproteins as risk factors for atherosclerosis].
    Schwandt P
    Klin Wochenschr; 1990; 68 Suppl 22():54-8. PubMed ID: 2087080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of glibenclamide and insulin on plasma high density lipoprotein in diabetics.
    Tamai T; Nakai T; Yamada S; Kobayashi T; Hayashi T; Kutsumi Y; Oida K; Takeda R
    Artery; 1981; 9(6):477-93. PubMed ID: 6802107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Changes in serum lipoproteins in cerebrovascular disease (author's transl)].
    Bruck J; Fischer M; Tschabitscher H
    Wien Klin Wochenschr; 1981 Oct; 93(19):604-9. PubMed ID: 7324470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of short-term modest weight loss on fasting and post-prandial lipoprotein sub-fractions in type 2 diabetes mellitus patients.
    Ybarra J; James RW; Makoundou V; Bioletto S; Golay A
    Diabetes Metab; 2001 Dec; 27(6):701-8. PubMed ID: 11852380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipoprotein alterations in hemodialysis: differences between diabetic and nondiabetic patients.
    González AI; Schreier L; Elbert A; Berg G; Beresan H; López G; Wikinski R
    Metabolism; 2003 Jan; 52(1):116-21. PubMed ID: 12524671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Very low density lipoprotein. Qualitative abnormalities in patients with premature coronary heart disease and in patients with insulin dependent diabetes.
    Mancini M; Pauciullo P; Cortese C; Rubba P; Riccardi G; Rivellese A
    Horm Metab Res Suppl; 1988; 19():13-5. PubMed ID: 3235056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of hypercholesterolaemia in the patient with diabetes.
    Packard C; Olsson AG
    Int J Clin Pract Suppl; 2002 Jul; (130):27-32. PubMed ID: 12296606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dyslipidaemia in diabetes mellitus. Review of the main lipoprotein abnormalities and their consequences on the development of atherogenesis.
    Vergès BL
    Diabetes Metab; 1999 Jun; 25 Suppl 3():32-40. PubMed ID: 10421991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma lipoprotein composition in type 2 diabetic patients.
    Møller A; Rasmussen L; Ledet T
    Scand J Clin Lab Invest; 1987 Nov; 47(7):731-8. PubMed ID: 3685873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Very low density lipoproteins in type II diabetes mellitus and risk of atherosclerosis.
    Schwandt P
    Horm Metab Res Suppl; 1985; 15():80-3. PubMed ID: 3865885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetic dyslipidemia.
    Chahil TJ; Ginsberg HN
    Endocrinol Metab Clin North Am; 2006 Sep; 35(3):491-510, vii-viii. PubMed ID: 16959582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum lipoproteins in patients with clinical signs of atherosclerosis: peripheral vascular and coronary heart disease.
    Kaliman J; Widhalm K; Strobl W
    Artery; 1980; 8(6):547-52. PubMed ID: 7259533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse effects of obesity on lipid and lipoprotein levels in insulin-dependent and non-insulin-dependent diabetes.
    Laakso M; Pyörälä K
    Metabolism; 1990 Feb; 39(2):117-22. PubMed ID: 2299984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacologic treatment of type 2 diabetic dyslipidemia.
    Moon YS; Kashyap ML
    Pharmacotherapy; 2004 Dec; 24(12):1692-713. PubMed ID: 15585439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of niceritrol (pentaerythritol tetranicotinate) on plasma lipoprotein concentration: increment of high density lipoprotein(HDL) cholesterol and HDL-cholesterol/low density lipoprotein cholesterol ratio in hypo-high density lipoproteinemia.
    Oida K; Nakai T; Tamai T; Kutsumi Y; Kobayashi T; Hayashi T; Yamada S; Takeda R
    Artery; 1982; 10(4):266-85. PubMed ID: 7181672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved lipoprotein surface and core lipid composition following intraperitoneal insulin delivery in insulin-dependent diabetes mellitus.
    Bagdade JD; Dunn FL
    Diabetes Metab; 1996 Dec; 22(6):420-6. PubMed ID: 8985650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.